Return on Equity (ROE)
since 2012
Calculation
Zoetis Inc., ROE, long-term trends, calculation
| ROE | = | 100 | × | Net income attributable to Zoetis1 | ÷ | Total Zoetis Inc. equity1 | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2020 | 43.46% | = | 100 | × | 1,638 | ÷ | 3,769 |
| Dec 31, 2019 | 55.39% | = | 100 | × | 1,500 | ÷ | 2,708 |
| Dec 31, 2018 | 65.35% | = | 100 | × | 1,428 | ÷ | 2,185 |
| Dec 31, 2017 | 48.81% | = | 100 | × | 864 | ÷ | 1,770 |
| Dec 31, 2016 | 55.21% | = | 100 | × | 821 | ÷ | 1,487 |
| Dec 31, 2015 | 31.74% | = | 100 | × | 339 | ÷ | 1,068 |
| Dec 31, 2014 | 44.47% | = | 100 | × | 583 | ÷ | 1,311 |
| Dec 31, 2013 | 53.62% | = | 100 | × | 504 | ÷ | 940 |
| Dec 31, 2012 | 10.83% | = | 100 | × | 436 | ÷ | 4,026 |
Based on: 10-K (filing date: 2021-02-16), 10-K (filing date: 2020-02-13), 10-K (filing date: 2019-02-14), 10-K (filing date: 2018-02-15), 10-K (filing date: 2017-02-16), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-27), 10-K (filing date: 2014-03-26), 10-K (filing date: 2013-03-28).
1 US$ in millions
Comparison to Competitors
Zoetis Inc., ROE, long-term trends, comparison to competitors
| Zoetis Inc. | Abbott Laboratories | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Eli Lilly & Co. | Gilead Sciences Inc. | Illumina Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2020 | 43.46% | 13.71% | 35.30% | 77.20% | -23.84% | 109.79% | — | 13.98% | 23.25% | 27.91% | 15.21% | 31.86% | 31.22% |
| Dec 31, 2019 | 55.39% | 11.86% | — | 81.07% | 6.66% | 319.09% | 23.91% | 21.72% | 25.42% | 37.99% | 25.77% | 19.08% | 19.34% |
| Dec 31, 2018 | 65.35% | 7.76% | — | 67.15% | 35.07% | 32.88% | 25.51% | 21.98% | 25.60% | 23.30% | 17.59% | 27.91% | 47.28% |
| Dec 31, 2017 | 48.81% | 1.54% | 104.16% | 7.84% | 8.58% | -1.76% | 22.64% | 26.41% | 2.16% | 6.97% | 29.47% | 19.51% | 12.99% |
| Dec 31, 2016 | 55.21% | 6.82% | 128.41% | 25.85% | 27.55% | 19.54% | 71.48% | 21.06% | 23.49% | 9.78% | 12.12% | 20.13% | -9.69% |
| Dec 31, 2015 | 31.74% | 20.85% | 130.39% | 24.71% | 10.97% | 16.53% | 97.70% | 24.97% | 21.66% | 9.94% | 10.75% | 17.40% | -59.19% |
| Dec 31, 2014 | 44.47% | 10.61% | 101.84% | 20.01% | 13.49% | 15.55% | 78.45% | 24.16% | 23.40% | 24.50% | 12.81% | 13.69% | -68.70% |
| Dec 31, 2013 | 53.62% | 10.23% | 91.90% | 23.00% | 16.91% | 26.57% | 27.05% | 8.17% | 18.68% | 8.85% | 28.83% | 21.74% | -32.81% |
| Dec 31, 2012 | 10.83% | 22.32% | 156.85% | 22.80% | 14.39% | 27.69% | 27.84% | 11.47% | 16.74% | 11.63% | 17.93% | 60.24% | -10.71% |
Based on: 10-K (filing date: 2021-02-16), 10-K (filing date: 2020-02-13), 10-K (filing date: 2019-02-14), 10-K (filing date: 2018-02-15), 10-K (filing date: 2017-02-16), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-27), 10-K (filing date: 2014-03-26), 10-K (filing date: 2013-03-28).
Comparison to Sector (Pharmaceuticals & Biotechnology)
Zoetis Inc., ROE, long-term trends, comparison to sector (pharmaceuticals & biotechnology)
| Zoetis Inc. | Pharmaceuticals & Biotechnology | |
|---|---|---|
| Dec 31, 2020 | 43.46% | — |
| Dec 31, 2019 | 55.39% | 29.60% |
| Dec 31, 2018 | 65.35% | 27.94% |
| Dec 31, 2017 | 48.81% | 14.50% |
| Dec 31, 2016 | 55.21% | 23.11% |
| Dec 31, 2015 | 31.74% | 22.96% |
| Dec 31, 2014 | 44.47% | 21.88% |
| Dec 31, 2013 | 53.62% | 20.86% |
| Dec 31, 2012 | 10.83% | 19.43% |
Based on: 10-K (filing date: 2021-02-16), 10-K (filing date: 2020-02-13), 10-K (filing date: 2019-02-14), 10-K (filing date: 2018-02-15), 10-K (filing date: 2017-02-16), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-27), 10-K (filing date: 2014-03-26), 10-K (filing date: 2013-03-28).
Comparison to Industry (Health Care)
Zoetis Inc., ROE, long-term trends, comparison to industry (health care)
| Zoetis Inc. | Health Care | |
|---|---|---|
| Dec 31, 2020 | 43.46% | — |
| Dec 31, 2019 | 55.39% | 23.37% |
| Dec 31, 2018 | 65.35% | 21.29% |
| Dec 31, 2017 | 48.81% | 13.56% |
| Dec 31, 2016 | 55.21% | 18.84% |
| Dec 31, 2015 | 31.74% | 18.48% |
| Dec 31, 2014 | 44.47% | 19.31% |
| Dec 31, 2013 | 53.62% | 18.98% |
| Dec 31, 2012 | 10.83% | 17.23% |
Based on: 10-K (filing date: 2021-02-16), 10-K (filing date: 2020-02-13), 10-K (filing date: 2019-02-14), 10-K (filing date: 2018-02-15), 10-K (filing date: 2017-02-16), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-27), 10-K (filing date: 2014-03-26), 10-K (filing date: 2013-03-28).